ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy.

Tomás Pascual et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.